“USFDA has conducted an inspection at Alembic Pharmaceuticals’ Oncology Injectable Formulation Facility located at Panelav from 4 th October, 2022 to 14th October, 2022.The USFDA issued a Form 483 with 4 procedural observations.
None of the observations are related to data integrity and management believes that they are addressable. “
Source:
| Subscribe To Our Free Newsletter |
